| Not Yet Recruiting | Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutat Lung Cancer (NSCLC), HER2 Expression, HER2 Gene Mutation | Phase 1 | 2026-08-01 |
| Not Yet Recruiting | Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Triple Negative Breast Cancer (TNBC), Early Setting, Early Stage Triple-Negative Breast Carcinoma, Triple -Negative Breast Cancer | Phase 3 | 2026-04-01 |
| Recruiting | Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas Sarcoma of Soft Tissue, Sarcoma, Sarcoma, Soft Tissue | N/A | 2025-12-11 |
| Recruiting | Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions Prostate Cancer (Adenocarcinoma) | N/A | 2025-11-17 |
| Recruiting | TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer Breast Cancer | — | 2025-11-06 |
| Recruiting | Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients Breast Cancer | N/A | 2025-10-14 |
| Recruiting | Contrast-enhanced Ultrasound for Sentinel Node Detection Melanoma, Breast Cancer, Head & Neck Cancer | Phase 2 / Phase 3 | 2025-09-18 |
| Recruiting | Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial Cisplatin-related Hearing Loss | Phase 3 | 2025-08-14 |
| Recruiting | Functional Liver After SBRT Liver Metastases | — | 2025-07-21 |
| Recruiting | Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Nec Radiation Necrosis, High Grade Glioma (III or IV), Brain Metastasases | Phase 3 | 2025-06-19 |
| Recruiting | Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Gastrointenstinal Stromal Tumor (GIST) | — | 2025-05-21 |
| Recruiting | Towards Cure Via Only Ultra-short ICB in CSCC Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Cancer, Cutaneous Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2025-05-14 |
| Recruiting | The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During I Ovarian Cancer, Epithelial Cancer, Fallopian Tube Cancer | Phase 1 / Phase 2 | 2025-05-01 |
| Recruiting | OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Breast Cancer Stage I, Triple Negative Breast Cancer (TNBC) | — | 2025-04-15 |
| Recruiting | Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT Non-Small Cell Lung Carcinoma, Advanced Non-Small Cell Squamous Lung Cancer, EGFR Gene Mutation | Phase 2 | 2025-03-03 |
| Recruiting | The Radium-select Study mCRPC, Male Urogenital Diseases | N/A | 2025-02-24 |
| Recruiting | Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer Early-onset Colorectal Cancer | — | 2025-01-27 |
| Not Yet Recruiting | The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer Prostate Cancer, Prostate Cancer Metastatic | N/A | 2024-12-01 |
| Recruiting | Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Colorectal Neoplasms, Floxuridine, Liver Metastases | Phase 3 | 2024-11-21 |
| Recruiting | Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer Urologic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases | Phase 2 | 2024-08-13 |
| Recruiting | Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER Patients With Non-small-cell Lung Cancer | N/A | 2024-08-08 |
| Recruiting | Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Tr Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2 | Phase 2 / Phase 3 | 2024-06-25 |
| Completed | Navigated Partial Nephrectomy Renal Cancer, Partial Nephrectomy | N/A | 2024-06-20 |
| Recruiting | LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients Metastatic Microsatellite-stable Colorectal Cancer | Phase 1 | 2024-06-18 |
| Recruiting | NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial Metastatic Breast Cancer | Phase 2 | 2024-06-12 |
| Not Yet Recruiting | Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer NSCLC | — | 2024-06-01 |
| Recruiting | Basket Study for Oligo-metastatic Breast Cancer HER2-positive Breast Cancer | Phase 2 | 2024-05-02 |
| Recruiting | Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breas Breast Cancer | N/A | 2024-04-12 |
| Recruiting | Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma Melanoma | Phase 1 / Phase 2 | 2024-03-08 |
| Active Not Recruiting | A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL Prostate Cancer | N/A | 2024-02-29 |
| Recruiting | Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab Urologic Neoplasms, Urogenital Neoplasms, Neoplasms by Site | Phase 2 | 2024-02-19 |
| Completed | The Food-effect on Alectinib Pharmacokinetics NSCLC | N/A | 2024-02-01 |
| Recruiting | Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations Resectable MMR-deficient Solid Tumors, Resectable MMR-proficient Solid Tumors | Phase 2 / Phase 3 | 2024-01-29 |
| Recruiting | PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB- Erectile Dysfunction Following Radical Prostatectomy | Phase 4 | 2024-01-15 |
| Recruiting | Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva | Phase 2 | 2024-01-01 |
| Recruiting | Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRA Breast Cancer | Phase 1 | 2023-12-18 |
| Unknown | Peri-operative Slow-paced Breathing to Reduce Anxiety in Breast Cancer Surgery Patients Anxiety | N/A | 2023-11-29 |
| Unknown | Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients Liver Metastases, Breast Cancer | N/A | 2023-10-19 |
| Recruiting | Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE) Prostate Cancer, Cervical Cancer, Bladder Cancer | N/A | 2023-08-29 |
| Recruiting | Galunisertib Combined With Capecitabine in Advanced CRC With PM Colorectal Cancer Metastatic, Peritoneal Carcinomatosis | Phase 1 / Phase 2 | 2023-07-28 |
| Unknown | Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker Drug Adherence Marker | Phase 4 | 2023-07-03 |
| Unknown | Effect of a Bundle of Non-pharmacological Interventions on the Stress Response to Surgery Surgical Injury, Stress, Physiological, Stress, Psychological | — | 2023-05-01 |
| Recruiting | Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostat Prostate Cancer | N/A | 2023-04-26 |
| Recruiting | COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Can Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive | Phase 2 | 2023-04-17 |
| Unknown | 'Cancer Patients Better Life Experience' Melanoma | N/A | 2023-04-15 |
| Unknown | Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy Locally Advanced Non-Small Cell Lung Cancer, Chemoradiotherapy, Cavitation Lung | N/A | 2023-04-01 |
| Recruiting | Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy Penile Cancer, Melanoma, Oral Cancer | N/A | 2023-04-01 |
| Unknown | Tracer-Guided Surgery for Recurrent Prostate Cancer Prostate Cancer | Phase 2 | 2023-02-15 |
| Active Not Recruiting | Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCL Carcinoma, Non-Small-Cell Lung | Phase 2 | 2023-01-03 |
| Active Not Recruiting | Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers Colorectal Cancer | Phase 2 | 2022-12-22 |
| Recruiting | DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Breast Cancer | N/A | 2022-10-07 |
| Recruiting | FMT to Convert Response to Immunotherapy Melanoma Stage III, Melanoma Stage IV | Phase 1 / Phase 2 | 2022-08-31 |
| Unknown | EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy Bladder Carcinoma | N/A | 2022-08-11 |
| Terminated | Sarcomas and DDR-Inhibition; a Combined Modality Study Soft Tissue Sarcoma Adult | Phase 1 | 2022-07-18 |
| Unknown | FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma Colorectal Cancer | N/A | 2022-07-13 |
| Unknown | Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases Breast Cancer, Breast Implant; Complications, Autoimmune Diseases | — | 2022-07-01 |
| Active Not Recruiting | Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemothera FIGO Stage III Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Carcinoma | Phase 2 | 2022-06-15 |
| Active Not Recruiting | Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer Renal Cell Carcinoma | Phase 2 | 2022-04-28 |
| Terminated | Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers Pancreatic Cancer, Colorectal Cancer, Non-small Cell Lung Cancer | Phase 1 | 2022-03-31 |
| Unknown | Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening CRC, Advanced Neoplasia | — | 2022-03-25 |
| Active Not Recruiting | Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC Urothelial Carcinoma, Bladder Cancer | Phase 2 | 2022-03-14 |
| Withdrawn | Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC Lung Cancer, Surgery, Circulating Tumor Cell | Phase 2 | 2022-01-01 |
| Completed | EBRT + Lu-PSMA for N1M0 Prostate Cancer Prostatic Neoplasm | Phase 1 | 2021-12-20 |
| Completed | Vessel- and Bone-based Ultrasound Registration Abdominal Cancer | N/A | 2021-12-05 |
| Terminated | Improved Implant for Reconstruction Purposes After Mandibular Resection Head and Neck Cancer, Oral Cancer | N/A | 2021-11-29 |
| Recruiting | The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy Prostate Cancer | N/A | 2021-11-17 |
| Completed | Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate C Prostate Cancer | — | 2021-11-01 |
| Completed | Pre-operative Immunotherapy in Stage II-III Urothelial Cancer Urothelial Carcinoma | Phase 1 | 2021-08-23 |
| Active Not Recruiting | Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma Malignant Melanoma Stage III | Phase 3 | 2021-07-08 |
| Unknown | Image-guided Navigation During Robotic Sentinel Node Removal Prostate Cancer | N/A | 2021-07-01 |
| Active Not Recruiting | Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas Soft Tissue Sarcomas | N/A | 2021-06-25 |
| Recruiting | The Prospective Observational COMPRAYA Cohort Study Second Cancer, Survivorship, Fertility Issues | — | 2021-06-18 |
| Unknown | Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing M Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction | N/A | 2021-06-01 |
| Completed | CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours Prostate Cancer, Solid Tumor, Adult | N/A | 2021-04-22 |
| Recruiting | Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local E Organ Preservation, Rectal Cancer, Quality of Life | N/A | 2021-04-16 |
| Unknown | Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer Ovarian Neoplasms | — | 2021-04-14 |
| Completed | Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial Breast Cancer | Phase 2 | 2021-03-23 |
| Active Not Recruiting | Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients Mesotheliomas Pleural | Phase 2 | 2021-03-01 |
| Recruiting | International Prospective Registry on Local Treatment Approaches in MLS Myxoid Liposarcoma | — | 2021-01-18 |
| Terminated | Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis Lung Cancer Stage I, Lung Cancer Stage II, Lung Metastases | N/A | 2021-01-13 |
| Unknown | Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT) Colorectal Neoplasms | Phase 2 / Phase 3 | 2020-09-09 |
| Completed | Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Mel Melanoma Stage III, Melanoma Stage IV | Phase 2 | 2020-09-08 |
| Completed | Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Sur Cutaneous Squamous Cell Carcinoma | Phase 2 | 2020-08-11 |
| Completed | Tracked Ultrasound for Patient Registration in Surgical Navigation During Abdominal Cancer Surgery Abdominal Cancer | — | 2020-07-13 |
| Unknown | Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study Prostate Cancer | — | 2020-03-11 |
| Recruiting | Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer Metastatic Breast Cancer | Phase 2 | 2020-02-21 |
| Completed | Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemot Testicular Cancer, Colorectal Neoplasms | N/A | 2020-02-18 |
| Completed | Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma Non Hodgkin Lymphoma, DLBCL, Cardiovascular Diseases | — | 2020-02-01 |
| Recruiting | Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy Metastatic Squamous Cell Carcinoma of the Vulva | Phase 2 | 2020-01-16 |
| Unknown | Improving the Safety of Fluoropyrimidine-based Chemotherapy Neoplasms | N/A | 2020-01-15 |
| Recruiting | Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemot Locally Advanced, Squamous Cell Carcinoma of the Vulva | Phase 2 | 2020-01-14 |
| Completed | Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IF Malignant Melanoma Stage III | Phase 1 / Phase 2 | 2020-01-07 |
| Active Not Recruiting | Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Ovarian Cancer | Phase 3 | 2020-01-01 |
| Withdrawn | LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615) Colorectal Cancer Metastatic | Phase 1 / Phase 2 | 2020-01-01 |
| Not Yet Recruiting | Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy Breast Cancer, Triple Negative Breast Cancer, HER2-positive Breast Cancer | N/A | 2020-01-01 |
| Completed | Propranolol in Angiosarcoma Angiosarcoma | Phase 2 | 2019-12-27 |
| Recruiting | Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metas Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Metastases From Melanoma, Brain Metastases From Breast Cancer | N/A | 2019-12-24 |
| Active Not Recruiting | The SONImage Study Breast Cancer | N/A | 2019-12-05 |
| Completed | INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue Head and Neck Cancer, Penile Cancer | — | 2019-11-13 |
| Unknown | Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal Cancer Colorectal Cancer, Peritoneal Carcinomatosis, MRI | N/A | 2019-10-28 |
| Active Not Recruiting | Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN) Rectal Cancer | Phase 2 | 2019-10-22 |
| Recruiting | Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO Breast Cancer | Phase 2 | 2019-10-04 |
| Unknown | Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. Non-small-cell Lung Carcinoma | N/A | 2019-08-22 |
| Unknown | Internet-based WOrk-related Cognitive Rehabilitation for Cancer Survivors: a Randomized Controlled Trial Cognitive Problems | N/A | 2019-08-03 |
| Active Not Recruiting | Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer Head and Neck Cancer | N/A | 2019-07-22 |
| Completed | ctDNA Guided Treatment of Early Resistance to Targeted Treatment Carcinoma, Non-Small-Cell Lung | N/A | 2019-07-17 |
| Completed | Health-related Quality of Life and Late Effects Among SURVivors of Cancer in Adolescence and Young Adulthood: Quality of Life, Late Effect, Survivorship | — | 2019-05-01 |
| Unknown | Assessing Health-related Quality of Life in Sarcoma Patients Sarcoma | — | 2019-05-01 |
| Completed | Improve Checkpoint-blockade Response in Advanced Urothelial Cancer Urothelial Carcinoma | Phase 1 / Phase 2 | 2019-05-01 |
| Unknown | Health After eaRly Menopause Due to Oophorectomy Surgical Menopause, BRCA1 Mutation, BRCA2 Mutation | — | 2019-02-11 |
| Recruiting | Blood Sampling of Healthy Volunteers for Immunological Research Healthy Volunteers | N/A | 2019-02-05 |
| Recruiting | The MR-Linac Technical Feasibility Protocol Tumors at All Sites Which Will Receive Radiotherapy | N/A | 2019-01-22 |
| Terminated | Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/o Stage III NSCLC | Phase 1 | 2018-12-28 |
| Terminated | T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive N Carcinoma, Non-Small-Cell Lung | Phase 2 | 2018-12-18 |
| Completed | Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lu Carcinoma, Non-Small-Cell Lung | Phase 2 | 2018-12-04 |
| Terminated | Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility Cervical Cancer | Phase 2 | 2018-11-01 |
| Completed | 18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC NSCLC Stage IV | N/A | 2018-10-25 |
| Completed | PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study Penile Cancer | Phase 2 | 2018-09-25 |
| Unknown | Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour Testicular Germ Cell Tumor | — | 2018-09-01 |
| Withdrawn | Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer Colorectal Cancer Metastatic | Phase 1 / Phase 2 | 2018-08-24 |
| Completed | ctDNA as a Biomarker for Treatment Response in HNSCC Carcinoma, Squamous Cell of Head and Neck | N/A | 2018-07-16 |
| Terminated | A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients Breast Cancer | Phase 2 | 2018-05-15 |
| Unknown | Clinical Impact of Dedicated MR Staging of Ovarian Cancer Ovarian Cancer | N/A | 2018-04-13 |
| Unknown | Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC Renal Cell Carcinoma | Phase 2 | 2018-03-28 |
| Terminated | Preoperative Breast Irradiation Breast Cancer | N/A | 2018-03-12 |
| Active Not Recruiting | Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer Stomach Cancer, Gastro Esophageal Junction Cancer | Phase 2 | 2018-03-07 |
| Completed | Vinorelbine in Advanced BRAF-like Colon Cancer Colon Cancer | Phase 2 | 2018-03-01 |
| Terminated | Early Response Evaluation in NSCLC Patients Treated With Immunotherapy NSCLC, Stage IV | N/A | 2018-01-23 |
| Completed | Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy Urothelial Carcinoma | Phase 1 | 2018-01-15 |
| Terminated | Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors Brain Tumor | — | 2018-01-12 |
| Completed | Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy Head and Neck Cancer | N/A | 2017-12-21 |
| Active Not Recruiting | Multicentric Randomised Trial for Resectable Gastric Cancer Gastric Cancer | Phase 2 | 2017-12-21 |
| Completed | Dose-Effect Relation of Salivary Gland Irradiation HNSCC | — | 2017-11-21 |
| Terminated | AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer Breast Cancer | Phase 2 | 2017-11-02 |
| Completed | Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer Ovarian Cancer Stage IV, Peritoneal Cancer, Fallopian Tube Cancer | Phase 1 / Phase 2 | 2017-11-01 |
| Withdrawn | Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC Non-Small Cell Lung Cancer | Phase 2 | 2017-11-01 |
| Active Not Recruiting | Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination. Stomach Neoplasm, Peritoneal Carcinomatosis | Phase 3 | 2017-10-01 |
| Completed | To Decrease Fatigue With Light Therapy Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma | Phase 3 | 2017-09-20 |
| Recruiting | A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS) Soft Tissue Sarcoma, Xenograft Model, 2D/3D Cell Cultures | N/A | 2017-09-09 |
| Completed | The Impact of a Web-based Patient Decision Aid for Women Considering Breast Reconstruction Breast Cancer | N/A | 2017-08-16 |
| Recruiting | "Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer Rectal Neoplasms | — | 2017-05-10 |
| Completed | Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel Prostate Cancer Metastatic, Metastasis | Phase 2 / Phase 3 | 2017-05-07 |
| Recruiting | Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer Colon Carcinoma | Phase 2 | 2017-03-29 |
| Completed | ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurren Immunotherapy, Head and Neck Neoplasms | Phase 1 / Phase 2 | 2017-02-28 |
| Active Not Recruiting | Management of Low-risk (Grade I and II) DCIS DCIS | N/A | 2017-02-13 |
| Completed | Bioimmunoradiotherapy (Cetuximab/RT/Avelumab) Carcinoma, Squamous Cell of Head and Neck | Phase 1 | 2017-02-01 |
| Active Not Recruiting | Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer Breast Cancer | Phase 3 | 2017-01-25 |
| Completed | Navigated Abdominal Lymph Node Dissections Image-guide Surgery, Lymph Node Metastasis | N/A | 2017-01-24 |
| Completed | Carboplatin-cyclophosphamide Combined With Atezolizumab Breast Cancer, Cervix Cancer, Ovarian Cancer | Phase 1 | 2017-01-01 |
| Unknown | Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients Stage III Skin Melanoma | Phase 1 | 2016-11-24 |
| Unknown | Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab Malignant Melanoma Stage III | Phase 2 | 2016-11-24 |
| Terminated | Pre- Versus Postoperative Accelerated Partial Breast Irradiation Breast Cancer, Cancer of the Breast, Neoplasms, Breast | N/A | 2016-11-10 |
| Completed | Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots Cocaine Addiction | EARLY_Phase 1 | 2016-11-01 |
| Unknown | The Effectiveness of Patient Navigation in Cancer Care Cancer | N/A | 2016-10-15 |
| Terminated | Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non S Carcinoma, Non-small Cell Lung | Phase 3 | 2016-10-14 |
| Completed | Study With Improved Solubility Pazopanib Pharmacokinetics of Pazopanib | EARLY_Phase 1 | 2016-09-15 |
| Terminated | Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Prostatic Neoplasms | Phase 1 | 2016-09-01 |
| Completed | The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shar Breast Cancer | — | 2016-09-01 |
| Completed | Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma Malignant Pleural Mesothelioma | Phase 2 | 2016-09-01 |
| Recruiting | The Drug Rediscovery Protocol (DRUP Trial) Cancer, Tumors, Neoplasm | Phase 2 | 2016-08-01 |
| Completed | HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma Melanoma, Skin Neoplasms | Phase 1 / Phase 2 | 2016-06-01 |
| Unknown | Lung Cancer Early Molecular Assessment Trial Carcinoma, Non-Small-Cell Lung | — | 2016-06-01 |
| Completed | Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Drug Safety Biomarkers | N/A | 2016-04-14 |
| Unknown | Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Canc Carcinoma, Non-Small Cell Lung | Phase 3 | 2016-04-01 |
| Unknown | Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin Neuroendocrine Carcinomas | Phase 2 | 2016-03-30 |
| Terminated | Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients Sarcoma, Soft Tissue Sarcomas | Phase 2 | 2016-03-17 |
| Unknown | Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients Metastatic Melanoma | Phase 2 | 2016-01-01 |
| Terminated | Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer Head and Neck Neoplasms | N/A | 2015-11-01 |
| Completed | Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223 Prostate Cancer Metastatic, Bone Metastases | — | 2015-10-30 |
| Completed | Molecular Stool Testing for Colorectal Cancer Surveillance Colorectal Cancer | — | 2015-10-01 |
| Unknown | Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients Breast Cancer | Phase 2 | 2015-08-01 |
| Completed | Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT) Head and Neck Cancer | N/A | 2015-07-23 |
| Completed | Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC Non-Small Cell Lung Cancer | Phase 2 | 2015-07-01 |
| Completed | Nivolumab in Patients With Recurrent Malignant Mesothelioma Malignant Pleural Mesothelioma | Phase 2 | 2015-07-01 |
| Unknown | Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer Colorectal Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms | Phase 1 / Phase 2 | 2015-06-01 |
| Completed | Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer Breast Cancer, Ovarian Cancer, Advanced Cancer | Phase 1 | 2015-05-01 |
| Unknown | Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors Breast Neoplasms, Cardiovascular Diseases | — | 2015-04-01 |
| Completed | Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines Neoplasms | N/A | 2015-03-01 |
| Completed | Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms Climacteric Symptoms, Breast Cancer Survivors | Phase 3 | 2015-02-01 |
| Completed | Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With R Prostate Cancer Metastatic, Bone Metastases | — | 2015-01-17 |
| Completed | Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen Breast Cancer | Phase 1 / Phase 2 | 2014-11-01 |
| Completed | Lapatinib Plus Trametinib in KRAS Mutant NSCLC Colorectal Cancer | Phase 1 / Phase 2 | 2014-10-07 |
| Unknown | Olaparib and Radiotherapy in Head and Neck Cancer Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell | Phase 1 | 2014-09-24 |
| Completed | Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma Metastatic Melanoma | Phase 3 | 2014-09-23 |
| Unknown | An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries Non Small Cell Lung Cancer Stage III | — | 2014-09-01 |
| Active Not Recruiting | High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer Breast Cancer | Phase 3 | 2014-09-01 |
| Completed | Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation Prostate Cancer, DNA, Androgen Receptor Abnormal | Phase 2 | 2014-08-28 |
| Completed | 4D FDG PET in Esophageal Cancer Esophageal Cancer | N/A | 2014-08-01 |
| Completed | Organ Motion and Early Tumor Response Measurement Esophageal Cancer, Chemoradiation | — | 2014-04-18 |
| Completed | Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC Colorectal Cancer | Phase 1 / Phase 2 | 2014-04-02 |
| Active Not Recruiting | Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 Breast Cancer, HER2 Positive | Phase 3 | 2013-12-01 |
| Completed | Olaparib and Radiotherapy in Inoperable Breast Cancer Locally Advanced Malignant Neoplasm, Inflammatory Breast Carcinoma, Triple-Negative Invasive Breast Carcinoma | Phase 1 | 2013-10-21 |
| Unknown | Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases Meningeal Carcinomatosis | Phase 2 | 2013-10-01 |
| Active Not Recruiting | Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treat Breast Cancer | Phase 2 | 2013-07-01 |
| Completed | Hippocampus Avoidance PCI vs PCI Small Cell Lung Cancer, Lung Cancer | Phase 3 | 2013-04-01 |
| Completed | PET Response During Chemoradiation of Lung Cancer NSCLC | N/A | 2013-03-21 |
| Completed | Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. Inoperable Locally Advanced Non Small Cell Lung Cancer | Phase 1 | 2013-02-28 |
| Completed | RCT of an Internet-based CBT Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer Sexual Dysfunction, Intimacy Problems, Breast Cancer Survivors | Phase 3 | 2012-12-01 |
| Completed | Adaptive Radiation Treatment for Head and Neck Cancer Head and Neck Cancer | Phase 3 | 2012-09-07 |
| Completed | Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningea Meningeal Carcinomatosis | N/A | 2012-09-01 |
| Unknown | PET Evaluation of Recurrent Differentiated Thyroid Cancer Thyroid Neoplasms, Differentiated Thyroid Cancer | — | 2012-08-01 |
| Unknown | Prospective Pilot Study ANDPrecise Breast Cancer | Phase 3 | 2012-06-01 |
| Completed | Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC NSCLC | Phase 1 | 2012-04-01 |
| Unknown | Study With T-cel Receptor Gene Therapy in Metastatic Melanoma Stage IV Skin Melanoma, Eye; Melanoma | Phase 1 / Phase 2 | 2012-03-01 |
| Completed | Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously Lung Cancer, Metastatic Lung Cancer | Phase 1 / Phase 2 | 2011-11-22 |
| Completed | The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics Psychosocial Issues, Cancer Genetics | N/A | 2011-10-01 |
| Completed | Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advan Malignant Solid Tumour | Phase 1 | 2011-04-11 |
| Unknown | Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metasta Metastatic Gastric Cancer, Adenocarcinoma of the Gastro-oesophageal Junction | Phase 2 | 2011-03-01 |
| Unknown | Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas Myxoid Liposarcoma of Soft Tissue | Phase 2 | 2010-12-15 |
| Completed | Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir Cancer | Phase 1 | 2010-09-01 |
| Completed | Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ova Epithelial Ovarian Cancer | Phase 2 | 2010-07-01 |
| Completed | Combined Modality Treatment of Sarcomas of the Extremities Sarcoma,Soft Tissue | Phase 1 | 2010-06-01 |
| Unknown | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and NSCLC | N/A | 2010-05-01 |
| Active Not Recruiting | Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer Breast Cancer | Phase 2 / Phase 3 | 2010-01-01 |
| Completed | Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer Breast Cancer | N/A | 2009-10-01 |
| Completed | Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma Malignant Pleural Mesothelioma | Phase 1 / Phase 2 | 2009-05-22 |
| Completed | Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients Breast Neoplasms | N/A | 2008-11-01 |
| Completed | Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study Breast Cancer, HER2 Positive | Phase 2 | 2008-09-01 |
| Suspended | Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer Breast Cancer | Phase 2 | 2008-07-01 |
| Terminated | Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment i Breast Cancer | Phase 2 / Phase 3 | 2008-04-01 |
| Unknown | Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Ex Menopausal Symptoms in Breast Cancer Patients With Treatment-Induced Complaints | Phase 3 | 2008-01-01 |
| Completed | Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity Breast Cancer | Phase 3 | 2007-06-01 |
| Terminated | Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD Breast Cancer | Phase 2 / Phase 3 | 2007-05-01 |
| Completed | Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines Neoplasms | Phase 1 | 2007-05-01 |
| Completed | Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer Ovarian Cancer | Phase 3 | 2007-02-01 |
| Unknown | Radiation Dose Intensity Study in Breast Cancer in Young Women Breast Cancer | Phase 3 | 2004-07-01 |
| Completed | Radiotherapy for Prostate Cancer: Conventional Dose Versus High Dose Prostatic Neoplasms | Phase 3 | 1997-06-01 |